ReviewFrontiers in neurology2026
Visual impairment in multiple sclerosis involving post-geniculate gray and white matter: above and beyond.
Review in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Visual impairment is one of the most common and disabling manifestations of multiple sclerosis (MS). While visual dysfunction related to optic neuritis and brainstem involvement is well recognized, visual impairment associated with post-geniculate visual pathways-including the optic radiations and visual cortex-remains comparatively under-studied and under-recognized in clinical practice. Increasing evidence from advanced neuroimaging, optical coherence tomography, and neuropsychological testing has demonstrated that lesions affecting post-geniculate white and gray matter contribute to both symptomatic and subclinical visual dysfunction in people with multiple sclerosis (PwMS). These abnormalities include homonymous visual field defects, visuoperceptual dysfunction, visual cognitive impairment, and higher-order ocular motor abnormalities. Cortical lesions and cortical thinning correlate with deficits in visual memory, visuospatial processing, and processing speed, while optic radiation damage contributes to retrograde transsynaptic degeneration and impaired visual information processing. Emerging eye-movement paradigms further suggest that higher-order ocular motor dysfunction reflects widespread gray matter involvement and may serve as a sensitive biomarker of disease burden. This review summarizes current histopathological and imaging evidence for post-geniculate pathway involvement in MS and discusses its clinical relevance for diagnosis, monitoring, and functional assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.